| 标题 |
A randomised, open, controlled trial for darunavir/cobicistat or Lopinavir/ritonavir combined with thymosin a1 in the treatment of novel coronavirus pneumonia (COVID-19)
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | INTERVENTION: DRV/c group:DRV/c (800mg/150mg QD) + Conventional treatment containing thymosin (1.6 mg SC QOD) ;LPV/r group:LPV/r (400mg/100mg bid) + Conventional treatment containing thymosin (1.6 mg SC QOD);other group:Conventional treatment containing thymosin (1.6 mg SC QOD) ; CONDITION: novel coronavirus pneumonia (COVID‐19) PRIMARY OUTCOME: Time to conversion of 2019‐nCoV RNA result from RI sample; SECONDARY OUTCOME: all cause mortality;Time to temperature |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
PDF的下载单位、IP信息已删除
彭于彦祖
pcr163
LaTeXer
tuanheqi
昏睡的蟠桃
浮游
GingerF
leaolf
小青椒
xun
馆长
子车茗
核桃
辛勤的诗柳
带头大哥
菠菜
Dean
七院
ccm
今天只做一件事
路人
蛇從革
唐泽雪穗
Serendipity
iNk
不安青牛
赫若魔
zcl
皖公网安备34019202002308
